Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Beaumont, T; van Nuenen, A; Broersen, S; Blattner, WA; Lukashov, VV; Schuitemaker, H
   Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course
   JOURNAL OF VIROLOGY
   
   T. Beaumont et al., "Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course", J VIROLOGY, 75(5), 2001, pp. 2246-2252
2. Kwa, D; Vingerhoed, J; Boeser-Nunnink, B; Broersen, S; Schuitemaker, H
   Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4(+)T-cell subsets are determined only by coreceptor expression
   JOURNAL OF VIROLOGY
   
   D. Kwa et al., "Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4(+)T-cell subsets are determined only by coreceptor expression", J VIROLOGY, 75(21), 2001, pp. 10455-10459
3. Beaumont, T; Broersen, S; van Nuenen, AD; Huisman, HG; Husman, AMD; Heeney, JL; Schuitemaker, H
   Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees
   JOURNAL OF VIROLOGY
   
   T. Beaumont et al., "Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees", J VIROLOGY, 74(17), 2000, pp. 7699-7707
4. van Rij, RP; Blaak, H; Visser, JA; Brouwer, M; Rientsma, R; Broersen, S; Husman, AMD; Schuitemaker, H
   Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1
   JOURNAL OF CLINICAL INVESTIGATION
   
   R.P. van Rij et al., "Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1", J CLIN INV, 106(8), 2000, pp. 1039-1052
5. van Rij, RP; Blaak, H; Visser, JA; Brouwer, M; Rientsma, R; Broersen, S; Husman, AMD; Schuitemaker, H
   Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1 (vol 106, pg 1039, 2000)
   JOURNAL OF CLINICAL INVESTIGATION
   
   R.P. van Rij et al., "Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1 (vol 106, pg 1039, 2000)", J CLIN INV, 106(12), 2000, pp. 1569-1569
6. Husman, AMD; van Rij, RP; Blaak, H; Broersen, S; Schuitemaker, H
   Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression
   JOURNAL OF INFECTIOUS DISEASES
   
   A.M.D. Husman et al., "Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression", J INFEC DIS, 180(4), 1999, pp. 1106-1115
7. VANRIJ RP; BROERSEN S; GOUDSMIT J; COUTINHO RA; SCHUITEMAKER H
   THE ROLE OF A STROMAL CELL-DERIVED FACTOR-I CHEMOKINE GENE VARIANT INTHE CLINICAL COURSE OF HIV-1 INFECTION
   AIDS
   
   R.P. Vanrij et al., "THE ROLE OF A STROMAL CELL-DERIVED FACTOR-I CHEMOKINE GENE VARIANT INTHE CLINICAL COURSE OF HIV-1 INFECTION", AIDS, 12(9), 1998, pp. 85-90
8. GROENINK M; SWART PJ; BROERSEN S; KUIPERS M; MEIJER DKF; SCHUITEMAKER H
   POTENT INHIBITION OF REPLICATION OF PRIMARY HIV TYPE-1 ISOLATES IN PERIPHERAL-BLOOD LYMPHOCYTES BY NEGATIVELY CHARGED HUMAN SERUM ALBUMINS
   AIDS research and human retroviruses
   
   M. Groenink et al., "POTENT INHIBITION OF REPLICATION OF PRIMARY HIV TYPE-1 ISOLATES IN PERIPHERAL-BLOOD LYMPHOCYTES BY NEGATIVELY CHARGED HUMAN SERUM ALBUMINS", AIDS research and human retroviruses, 13(2), 1997, pp. 179-185
9. SCHUITEMAKER H; FOUCHIER RAM; BROERSEN S; GROENINK M; KOOT M; VANTWOUT AB; HUISMAN HG; TERSMETTE M; MIEDEMA F
   ENVELOPE V2 CONFIGURATION AND HIV-1 PHENOTYPE - CLARIFICATION
   Science
   
   H. Schuitemaker et al., "ENVELOPE V2 CONFIGURATION AND HIV-1 PHENOTYPE - CLARIFICATION", Science, 268(5207), 1995, pp. 115-115
10. GROENINK M; MOORE JP; BROERSEN S; SCHUITEMAKER H
    EQUAL LEVELS OF GP120 RETENTION AND NEUTRALIZATION RESISTANCE OF PHENOTYPICALLY DISTINCT PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS UPON SOLUBLE CD4 TREATMENT
    Journal of virology
    
    M. Groenink et al., "EQUAL LEVELS OF GP120 RETENTION AND NEUTRALIZATION RESISTANCE OF PHENOTYPICALLY DISTINCT PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS UPON SOLUBLE CD4 TREATMENT", Journal of virology, 69(1), 1995, pp. 523-527
11. GROENINK M; FOUCHIER RAM; BROERSEN S; BAKER CH; VANDERJAGT RCM; MIEDEMA F; HUISMAN HG; TERSMETTE M; SCHUITEMAKER H
    ROLE OF THE HIV-1 GP120 DOMAINS V1, V2, AND V3 IN DETERMINING CYTOPATHOGENICITY
    Journal of cellular biochemistry
    
    M. Groenink et al., "ROLE OF THE HIV-1 GP120 DOMAINS V1, V2, AND V3 IN DETERMINING CYTOPATHOGENICITY", Journal of cellular biochemistry, 1993, pp. 29-29
12. GROENINK M; FOUCHIER RAM; BROERSEN S; BAKER CH; KOOT M; VANTWOUT AB; HUISMAN HG; MIEDEMA F; TERSMETTE M; SCHUITEMAKER H
    RELATION OF PHENOTYPE EVOLUTION OF HIV-1 TO ENVELOPE V2 CONFIGURATION
    Science
    
    M. Groenink et al., "RELATION OF PHENOTYPE EVOLUTION OF HIV-1 TO ENVELOPE V2 CONFIGURATION", Science, 260(5113), 1993, pp. 1513-1516